EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...

The results – presented at the ESMO cancer congress and simultaneously published in Annals of Oncology – come after seven ...

On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...

Millions of women worldwide live with endometriosis, which causes symptoms like pain and extreme tiredness and, if untreated, ...

Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher ...

Lila Sciences' already impressive $235 million first round financing has continued to build and has now closed at $350 ...

The European Society for Medical Oncology (ESMO) 2025 will take place 17th to 21st October in Berlin, Germany. The Congress ...

In the final episode of our special Frontiers Health limited series of the pharmaphorum podcast, web editor Nicole Raleigh ...

The filing of the legal action comes just a few days after J&J suffered a major setback in its defence in the US against ...

The 7th Annual AI in Drug Discovery Conference, hosted by SAE Media Group, takes place 9-10 March 2026 at Hilton London ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...